Annual report
7133.TEDINET S100R4MH
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 81
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥5.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥5.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥530m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥519m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥558m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥506m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥251m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥122m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥64m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥534m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥487m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥383m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥328m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥97m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥33m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥14m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.7bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.5bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥609m | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥503m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥470m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥568m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥720m | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥568m | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥720m | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥538m | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥227m | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥342m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥485m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥352m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥383m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥320m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥78m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥165m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥111m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥17m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥37m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥53.92 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.9 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.99 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.9 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,282.04 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.82 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.32 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥207.61 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥153.22 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥178.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.36 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥42,435.9 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 50.9% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.4% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.3% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 30.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 39.1% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,572,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,499,100 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,369 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,074 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,074 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 442 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 329 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 312 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 283 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 226 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 94
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥83m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 35 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥31m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥31m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥210m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥105m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥12m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥9m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥710m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥388m |
| Care Planning Servicereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥25,000 |
| Care Planning Servicereportable segment | employees | at 2023-03-31 | 21 pure |
| Care Planning Servicereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥132m |
| Care Planning Servicereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥132m |
| Care Planning Servicereportable segment | segment assets | at 2023-03-31 | ¥32m |
| Care Planning Servicereportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥9m |
| Home Visit Pharmacist Servicereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥115m |
| Home Visit Pharmacist Servicereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥61m |
| Home Visit Pharmacist Servicereportable segment | employees | at 2023-03-31 | 309 pure |
| Home Visit Pharmacist Servicereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.8bn |
| Home Visit Pharmacist Servicereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.8bn |
| Home Visit Pharmacist Servicereportable segment | segment assets | at 2023-03-31 | ¥1.8bn |
| Home Visit Pharmacist Servicereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥666m |
| Hospital Discharge Support Servicereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2m |
| Hospital Discharge Support Servicereportable segment | employees | at 2023-03-31 | 13 pure |
| Hospital Discharge Support Servicereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥40m |
| Hospital Discharge Support Servicereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥40m |
| Hospital Discharge Support Servicereportable segment | segment assets | at 2023-03-31 | ¥14m |
| Hospital Discharge Support Servicereportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥23m |
| Kirari Primereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥5m |
| Kirari Primereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥3m |
| Kirari Primereportable segment | employees | at 2023-03-31 | 21 pure |
| Kirari Primereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥634m |
| Kirari Primereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥634m |
| Kirari Primereportable segment | segment assets | at 2023-03-31 | ¥117m |
| Kirari Primereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥390m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥120m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥66m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥6.6bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥6.6bn |
| —segment total | segment assets | at 2023-03-31 | ¥2.0bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥203m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥71m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥919m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥14m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥14m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥16m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥15m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥25m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥13m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥828m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥315m |
| Care Planning Servicereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥110,000 |
| Care Planning Servicereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥84,000 |
| Care Planning Servicereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥123m |
| Care Planning Servicereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥123m |
| Care Planning Servicereportable segment | segment assets | at 2022-03-31 | ¥22m |
| Care Planning Servicereportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥7m |
| Home Visit Pharmacist Servicereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥128m |
| Home Visit Pharmacist Servicereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥51m |
| Home Visit Pharmacist Servicereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Home Visit Pharmacist Servicereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Home Visit Pharmacist Servicereportable segment | segment assets | at 2022-03-31 | ¥1.6bn |
| Home Visit Pharmacist Servicereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥579m |
| Hospital Discharge Support Servicereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Hospital Discharge Support Servicereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥66m |
| Hospital Discharge Support Servicereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥66m |
| Hospital Discharge Support Servicereportable segment | segment assets | at 2022-03-31 | ¥16m |
| Hospital Discharge Support Servicereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥18m |
| Kirari Primereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥8m |
| Kirari Primereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥784,000 |
| Kirari Primereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥433m |
| Kirari Primereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥433m |
| Kirari Primereportable segment | segment assets | at 2022-03-31 | ¥93m |
| Kirari Primereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥259m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥136m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥54m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.8bn |
| —segment total | segment assets | at 2022-03-31 | ¥1.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥848m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥140m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥834m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 987
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember | 8420000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember | 110000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember | － | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 136462000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3577000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 140039000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember_ReconcilingItemsMember | 25129000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_NonConsolidatedMember | 165168000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember | 5821001000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember | 634167000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember | 131593000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember | 40147000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 6626911000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 30537000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 6657448000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember | 6657448000 | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember | 5821001000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember | 634167000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember | 131593000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember | 40147000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 6626911000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 30537000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 6657448000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember | 6657448000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember | 665828000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember | 390002000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember | -9094000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember | -23126000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 1023611000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -104835000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 918775000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember | -388476000 | JPY |
| Operating income | CurrentYearDuration_NonConsolidatedMember | 530298000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember | 1831926000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000KirariPrimeReportableSegmentsMember | 117326000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000CarePlanningServiceReportableSegmentsMember | 31804000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E37198-000HospitalDischargeSupportServiceReportableSegmentsMember | 13862000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_ReportableSegmentsMember | 1994920000 | JPY |
| Assets | CurrentYearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 209728000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |